Fig. 3From: Intellectual property and access to medicines: mapping public attitudes toward pharmaceuticals during the United States-Mexico-Canada Agreement (USMCA) negotiation processA Comments publicly available in the USTR-2017-0006 Docket. B Comments related to pharmaceuticals for human use. C Classes of stakeholders that submitted pharmaceuticals-related commentsBack to article page